#CVCT2020

Carlos G Santos-Gallego, MD

SantosGallegoMD

Day 2 of @CVCTForum #CVCT2020 Use of biomarkers in clinical trials!!!Lawrence Fine from NIH on pros and cons of biomarkers in trials. Do they help overcome challenges and reduce sample

Dr.RajivSankaranarayanan PhD FESC FRCP MBBS

DrRajivsankar

Iconic #heartfailure trialist @FaiezZANNAD presents meta-analysis of EMPEROR-Reduced and DAPA-HF trials #CVCT2020 @FaiezZANNAD @drdargaray @lucreciamburgos @ersied727 @CVCTForum @SantosGallegoMD @rachkataria @AlexNowbar @vbluml @KevinShahMD

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.